Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Exagen Inc. (NASDAQ: XGN)
XGN Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
6.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-0.90%
XGN Stock Analysis
XGN
PE Ratio:
XGN
PEG Ratio:
Not Available
XGN
Forward EPS Growth (12 month):
0.00%
XGN
PS Ratio:
1.6
XGN
PSG Ratio:
0.1
XGN
Forward Revenue Growth (12 month):
11.00%
XGN Articles
No data was found